MU
McGill University / Research Institute of the McGill University Health Centre at AMP 2026
Nov 10–14, 2026 Seattle, WA ~2k attendees Website
McGill University / Research Institute of the McGill University Health Centre brings 2 presentations to AMP 2026 in Seattle. Its programme centres on liquid biopsy in solid tumours and integrated sequencing in haematology. The liquid biopsy work looks at blood-based biomarkers for picking up treatment response early and for monitoring disease over time.
| Organization | AMP 2026 Attendance |
|---|---|
MU McGill University / Research Institute of the McGill University Health Centre Montreal, Canada | |
Montreal research university and the research arm of its affiliated hospital network, covering genomics, cancer and liquid biopsy research. | Workshop Wed, Nov 11 2:00pm–2:50pm See More, Sooner: Integrated NGS for Deeper Hematologic Insights RNA-based fusion panels combined with custom cancer panels to detect fusions, copy number and point mutations in blood cancers. Talk Sat, Nov 14 11:00am–11:45am Liquid Biopsy Biomarkers for Early Detection of Treatment Response and Disease Monitoring Circulating tumor DNA and other blood biomarkers for tracking residual disease, treatment response, and the barriers to wider use. |
Instantly find 20 buyers from McGill University / Research Institute of the McGill University Health Centre
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with the Association for Molecular Pathology. Organization details are derived from AMP’s published lists. Submit a correction